Decay-accelerating factor

Decay-accelerating factor (DAF), also known as CD55 or Cromer blood group system, is a protein that in humans is encoded by the CD55 gene. DAF regulates the complement system on the cell surface to prevent the assembly of the complement membrane attack complex (MAC) on host cells.

Function

Decay-accelerating factor is involved in the regulation of the complement cascade. It protects cells from complement-mediated injury by inhibiting the C3 convertases, C4b2a and C3bBb, and by disrupting the function of these convertases.

Clinical significance

Deficiency of DAF can lead to paroxysmal nocturnal hemoglobinuria (PNH), a rare, acquired, potentially life-threatening disease of the blood characterized by complement-mediated intravascular hemolysis.

Interactions

Decay-accelerating factor has been shown to interact with Complement component 3 and Complement component 4b.

See also

• Complement system
• Paroxysmal nocturnal hemoglobinuria
• Complement component 3
• Complement component 4b

External links

• Decay-accelerating factor at WikiMD

Decay-accelerating factor Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski